and antigen presentation. Macrophages tailor their response to their local microenvironment. In the cutaneous setting, macrophages participate in the immune response to diverse stimuli such as ...

The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

Corticosteroids inhibit antigen presentation, cytokine production ... The monocyte effect. Monocytes/macrophages (promonocytes in the bone marrow, circulating monocytes, tissue macrophages ...

Another company developing macrophage therapies is Carisma Therapeutics. The company’s portfolio consists of chimeric antigen ...

Carisma Therapeutics (CARM) announced the upcoming presentation of new pre-clinical data on its anti-GPC3 in vivo chimeric antigen receptor ...